Investors
LYPHE are a private and independent group. We have built all of our businesses from the ground up, and boast the largest market share in the U.K. today. For information on investing in LYPHE, please get in touch.
LYPHE is Europe’s most popular cannabis clinical telehealth and dispensing ecosystem. We own the medical cannabis supply chain vertically from digital clinical care, manufacturing medical cannabis, to patient home delivery.
Our pursuit is for patient access to be mainstream and global.
Investors news
7 April 2021
INTERVIEW: Co-founder of LYPHE Group Jonathan Nadler talks about entering a Golden Age for European Cannabis
Interviews, Lyphe Group
9 March 2021
Lyphe Group supports MedCann ID to protect patients from unfair harassment
DG, Lyphe Group
Investor Enquiries
Thank you for filling out your information, one of our team members will be in touch shortly.
The LYPHE Group Team
